#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3992284	B	Binding affinity to recombinant full-length N-terminal hexahistidine-tagged c-Myc (353 to 437 residues) bHLH-ZIP domain (unknown origin) expressed in Escherichia coli BL21 DE3 (pLysS) by fluorescence polarization assay	Homo sapiens	27	ALA3991946	assay format	Patent Bioactivity Data
2.	ALA3992286	B	Binding affinity to human hexahistidine-tagged Max p21 bHLH-ZIP domain expressed in Escherichia coli M15 (pRep4) at 10 uM by fluorescence polarization assay	Homo sapiens	6	ALA3991946	assay format	Patent Bioactivity Data
3.	ALA3992289	B	Binding affinity to recombinant full-length N-terminal hexahistidine-tagged c-Myc (353 to 437 residues) bHLH-ZIP domain (unknown origin) expressed in Escherichia coli BL21 DE3 (pLysS) assessed as changes in shape or intensity of CD spectrum at 5 uM by circular dichroism assay	Homo sapiens	6	ALA3991946	assay format	Patent Bioactivity Data
4.	ALA3992294	B	Inhibition of recombinant full-length N-terminal hexahistidine-tagged c-Myc (353 to 437 residues) bHLH-ZIP domain (unknown origin) expressed in Escherichia coli BL21 DE3 (pLysS)/human hexahistidine-tagged Max p21 expressed in Escherichia coli M15 (pRep4) assessed as disruption of E-Box DNA binding preincubated for 30 mins with c-Myc followed by Max p21 and E-box element addition measured after 15 mins by electrophoretic mobility shift assay	Homo sapiens	6	ALA3991946	assay format	Patent Bioactivity Data
5.	ALA3992296	F	Cytotoxicity against human HL60 cells expressing c-Myc assessed as growth inhibition after 4 to 5 days by MTT assay	Homo sapiens	16	ALA3991946	cell-based format	Patent Bioactivity Data
6.	ALA3992297	F	Cytotoxicity against human Daudi Burkitt lymphoma cells expressing c-Myc assessed as growth inhibition after 4 to 5 days by MTT assay	Homo sapiens	15	ALA3991946	cell-based format	Patent Bioactivity Data
7.	ALA3992298	A	Cytotoxicity against non-transformed rat TGR1 assessed as growth inhibition after 4 to 5 days by MTT assay	Rattus norvegicus	11	ALA3991946	cell-based format	Patent Bioactivity Data
8.	ALA3992299	A	Cytotoxicity against c-Myc null rat TGR1 reconstituted with HMGA1b or MT-MC1 assessed as growth inhibition after 4 to 5 days by MTT assay	Rattus norvegicus	11	ALA3991946	cell-based format	Patent Bioactivity Data
9.	ALA3992300	B	Inhibition of recombinant c-Myc/Max (unknown origin) expressed in human HL60 cells assessed as disruption of c-Myc/Max association after 6 hrs by co-immunoprecipitation assay	Homo sapiens	4	ALA3991946	cell-based format	Patent Bioactivity Data
10.	ALA3992301	B	Inhibition of recombinant c-Myc/Max (unknown origin) expressed in human HL60 cells assessed as disruption of c-Myc/Max association after 16 hrs by co-immunoprecipitation assay	Homo sapiens	4	ALA3991946	cell-based format	Patent Bioactivity Data
11.	ALA3992302	U	Metabolic stability of the compound		5	ALA3991946	assay format	Patent Bioactivity Data